Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy

被引：130
|
作者：
Thibodeau, Jacques [1 ]
Bourgeois-Daigneault, Marie-Claude [1 ]
Lapointe, Rejean [2 ,3 ]
机构：
[1] Univ Montreal, Dept Microbiol & Immunol, Lab Immunol Mol, Montreal, PQ H3C 3J7, Canada
[2] Univ Montreal, Notre Dame Hosp, CRCHUM, Montreal, PQ H3C 3J7, Canada
[3] Univ Montreal, Inst Canc Montreal, Montreal, PQ H2L 4M1, Canada
来源：
ONCOIMMUNOLOGY | 2012年 / 1卷 / 06期
基金：
加拿大健康研究院;
关键词：
cancer; HLA; immunotherapy; MHC Class II; tumor; vaccine; CD4(+) T-CELLS; CHRONIC LYMPHOCYTIC-LEUKEMIA; INVARIANT CHAIN; HLA-DR; TUMOR-CELLS; METASTATIC MELANOMA; IMMUNE-RESPONSE; B-CELLS; EXPRESSION; CIITA;
D O I：
10.4161/onci.21205
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The success of immunotherapy relies on the participation of all arms of the immune system and the role of CD4(+) T lymphocytes in preventing tumor growth is now well established. Understanding how tumors evade immune responses holds the key to the development of cancer immunotherapies. In this review, we discuss how MHC Class II expression varies in cancer cells and how this influences antitumor immune responses. We also discuss the means that are currently available for harnessing the MHC Class II antigen presentation pathway for the development of efficient vaccines to activate the immune system against cancer.
引用
收藏
页码：908 / 916
页数：9
相关论文
共 50 条
  • [31] Towards a systems understanding of MHC class I and MHC class II antigen presentation
    Neefjes, Jacques
    Jongsma, Marlieke L. M.
    Paul, Petra
    Bakke, Oddmund
    NATURE REVIEWS IMMUNOLOGY, 2011, 11 (12) : 823 - 836
  • [32] Towards a systems understanding of MHC class I and MHC class II antigen presentation
    Jacques Neefjes
    Marlieke L. M. Jongsma
    Petra Paul
    Oddmund Bakke
    Nature Reviews Immunology, 2011, 11 : 823 - 836
  • [33] ATGs help MHC class II, but inhibit MHC class I antigen presentation
    Loi, Monica
    Gannage, Monique
    Munz, Christian
    AUTOPHAGY, 2016, 12 (09) : 1681 - 1682
  • [34] The MHC Class II Antigen-Processing and Presentation Pathway Is Dysregulated in Type 1 Diabetes
    Gilles, Ambroise
    Hu, Lan
    Virdis, Francesca
    Sant'Angelo, Derek B.
    Dimitrova, Nevenka
    Hedrick, Joseph A.
    Denzin, Lisa K.
    JOURNAL OF IMMUNOLOGY, 2023, 211 (11): : 1630 - 1642
  • [35] The MHC class II antigen presentation pathway in human monocytes differs by subset and is regulated by cytokines
    Lee, Justin
    Tam, Hanson
    Adler, Lital
    Ilstad-Minnihan, Alexandra
    Macaubas, Claudia
    Mellins, Elizabeth D.
    PLOS ONE, 2017, 12 (08):
  • [36] MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
    W Walter
    K Lingnau
    E Schmitt
    M Loos
    M J Maeurer
    British Journal of Cancer, 2000, 83 : 1192 - 1201
  • [37] MHC class II antigen presentation pathway in marine tumours: tumour evasion from immunosurveillance?
    Walter, W
    Lingnau, K
    Schmitt, E
    Loos, M
    Maeurer, MJ
    BRITISH JOURNAL OF CANCER, 2000, 83 (09) : 1192 - 1201
  • [38] Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases
    Ghittoni, Raffaella
    Napolitani, Giorgio
    Benati, Daniela
    Uliveri, Cristina
    Patrussi, Laura
    Pasini, Franco Laghi
    Lanzavecchia, Antonio
    Baldari, Cosima T.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (11) : 2885 - 2893
  • [39] Cordyceps militaris modulates presentation of exogenous antigen associated with MHC class I and MHC class II pathway in dendritic cells.
    Shin, Seulmee
    Kwon, Jeonghak
    Lee, Sungwon
    Moon, Sunhee
    Lee, Seungjeong
    Lee, Chongkil
    Cho, Kyunghea
    Kim, Kyungjae
    JOURNAL OF IMMUNOLOGY, 2009, 182
  • [40] MHC class II molecules on the move for successful antigen presentation
    Rocha, Nuno
    Neefjes, Jacques
    EMBO JOURNAL, 2008, 27 (01): : 1 - 5
12345